The incidence of fragility fractures has increased epidemically. Espec
ially patients with senile dementia (including Alzheimer's disease) ha
ve a greatly increased risk of fragility fractures. Aluminum inhibits
bone mineralization; the greater the aluminium exposure, the higher th
e risk of an early fracture. Aluminium is neurotoxic and may, in addit
ion to genetic factors, play a role in the development of Alzheimer's
disease by contributing to the formation of the characteristic beta-am
yloid and neurofibrillary tangles, Thus, a common denominator between
Alzheimer's disease and bone fragility may be a chronic low-grade alum
inum intoxication. The epidemic of fragility fractures may be caused b
y increased aluminium exposure-due to the use of aluminum cooking pots
or the pollution acidification of our environment, In our pilot study
of 26 hip-fracture patients (13 patients with Alzheimer's disease and
13 individually age-and gender-matched non-demented patients), the al
uminum content, determined mass-spectrometrically, was higher in trabe
cular bone biopsies from the patients with Alzheimer's disease than fr
om the non-demented patients (p=0.005). The aluminum content was also
higher in the younger of the 26 patients (p=0.02). Our findings agree
with the hypothesis that aluminum plays a role in the development of A
lzheimer's disease and bone fragility.